{
    "nct_id": "NCT04248582",
    "official_title": "Phase 1 Dose-Frequency Escalation Study of Neoadjuvant Cryotherapy in Locally Advanced Esophageal Cancer",
    "inclusion_criteria": "Adult patients with locally advanced esophageal cancer will be eligible to participate in the study. Eligible patients must have a histologically proven diagnosis of esophageal adenocarcinoma, esophageal squamous cell carcinoma, adenosquamous carcinoma, or gastro-esophageal junctional adenocarcinoma. Locally advanced esophageal cancer will be defined as absence of distant metastases on positron emission tomography-computed tomography (PET-CT) and a TNM stage of IIA to IIIC, as defined by endoscopic ultrasound and PET-CT\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Pediatric patients (age less than 18 years)\n2. Superficial esophageal cancer\n3. Inability to pass the orogastric decompression tube into the stomach\n4. Coagulopathy (INR > 2 or platelet count < 50,000/cubic millimeter).\n5. Inability to provide informed consent\n6. Eastern Cooperative Oncology Group (ECOG) performance status â‰¥3\n7. Pregnancy",
    "miscellaneous_criteria": ""
}